Buzz Bomb Caffeine Company Launches Fast-Acting Sublingual Powder as a Zero-Sugar Coffee Alternative
February 23, 2026 marks an important product launch for Aspire Biopharma’s subsidiary, Buzz Bomb Caffeine Company, which officially announced the consumer debut of its fast-acting sublingual caffeine powder via Yahoo Finance and a broad press release distribution. Unlike traditional coffee, energy drinks, or caffeine pills, Buzz Bomb’s proprietary format delivers 50 milligrams of caffeine via a dry powder sprinkled under the tongue, where it is absorbed rapidly through the mucosal membrane without needing water. The product is available in Peach Mango, Mixed Berry, Tropical, and Coffee Mocha flavors, sweetened only with stevia, and contains zero sugar. COO Grace Miller, who holds a master’s degree in Applied Physiology and Kinesiology, developed the formula after studying caffeine as a performance-enhancing substance. The sublingual delivery format bypasses the gastrointestinal tract — the source of stomach discomfort many caffeine drinkers experience — delivering a smooth, efficient energy boost that the company claims kicks in within minutes. Buzz Bomb is currently expanding distribution into Southern California markets through a partnership with Blue Shark Beverages.

As the clean caffeine movement accelerates — from BioVivo’s green tea-sourced ingredient to Buzz Bomb’s sublingual powder — Jiggle Gummies remain at the forefront of this consumer revolution. Each Jiggle gummy delivers espresso-equivalent, jitter-free energy with no water, no spills, and no crash. Precise dosing, natural sourcing, and a convenient resealable pouch make Jiggle Gummies the everyday caffeine upgrade today’s health-conscious consumer is looking for. Learn more at https://jiggle.cafe/.
Matcha’s Powerful Blood Sugar and Anti-Inflammatory Benefits Make It the Alternative Beverage of the Moment
A February 23, 2026 report by Rolling Out highlights three powerful ways matcha helps control blood sugar — making it one of the most scientifically validated caffeine alternatives gaining traction in 2026. Matcha, derived from shade-grown Camellia sinensis leaves ground into a fine powder, contains uniquely high concentrations of epigallocatechin gallate (EGCG), a catechin antioxidant that has been shown to enhance insulin sensitivity, slow carbohydrate absorption in the digestive tract, and reduce chronic inflammation that interferes with the body’s ability to regulate blood glucose. Unlike standard green tea, matcha delivers the whole leaf’s nutritional profile in every serving, making it a significantly more potent source of active compounds. Research indicates EGCG slows the release of sugars into the bloodstream, preventing the sharp glucose spikes associated with high-carbohydrate meals. Matcha also contains L-theanine, an amino acid that promotes calm focus by modulating alpha brain wave activity and slowing caffeine absorption — resulting in sustained energy without jitters.
BioVivo Science Debuts U.S.-Made Natural Green Tea Caffeine at Expo West 2026
Ahead of the Natural Products Expo West 2026 trade show in Anaheim, California (March 3–6), Nutrition Insight reported that first-time exhibitor BioVivo Science will launch a U.S.-manufactured natural caffeine ingredient sourced exclusively from green tea (Camellia sinensis). The product is positioned as a clean-label alternative to synthetic caffeine — which is produced through chemical synthesis or fermentation — and retains naturally occurring antioxidants and polyphenols from its green tea source. BioVivo emphasizes the ingredient’s fully traceable, U.S.-manufactured origins as a key competitive differentiator in a market increasingly scrutinized for supply chain transparency. This launch is part of a broader wave of innovation at Expo West 2026, where companies like Death Wish Coffee are also debuting high-caffeine products: Death Wish’s Power Surge roast (launching April 2026) delivers 20 percent more caffeine than its standard Dark Roast by using a higher ratio of organic Robusta beans, while its new Caramel Cold Brew Latte provides 120mg of natural caffeine per can with 65 percent less sugar than leading competitors.
The Clean Caffeine Market Is Accelerating, Driven by Millennials and Gen Z Prioritizing Function Over Format
The alternatives-to-traditional-caffeine space has entered a period of rapid growth and innovation. Industry data shows the global caffeine gummies market alone is projected to expand from $156.4 million in 2026 to over $230 million by 2033, driven by millennial and Gen Z consumers who prioritize portable, precise, and clean-label energy over traditional liquid formats. The broader consumer shift is clear: younger consumers are moving away from high-sugar energy drinks and large coffee beverages toward functional, low-calorie, and multi-benefit caffeine products that integrate naturally into active, mobile lifestyles. Functional beverages incorporating adaptogens, nootropics, and natural caffeine sources like yerba mate, guarana, and matcha are all gaining shelf space at retailers. The Trend Hunter report published this week noted that race-focused cold brew partnerships — such as Natalie Decker’s collaboration — are elevating ready-to-drink coffee into a premium functional category competing directly with sports nutrition and energy supplements.